+1 (941) 951-0126
    • Skip to content
    • About Us
      • Leadership Team
      • Scientific Advisors
      • Board of Directors
      • Partnerships, Collaborations and Joint Development Agreements
    • A New Paradigm
      • Human Microbiome
      • Drug Discovery
      • MiNE™ Platform
    • Intellectual Property
    • Pipeline
      • Product Pipeline
      • Partnerships
    • News
      • In the News
      • Press Releases
    • Careers
    • Contact
    In the News

    Quorum Innovations is included in Silicon Valley Bank’s report on Microbiome Investment Trends.

    August 22, 2017 Quorum Innovations

    Quorum Innovations is included in SVB Analytics – Emerging Healthcare: / 2017

    Microbiome Investment Trends

     

    Download a PDF of Full Report

    0
    SHARES
    FacebookTwitter

    Post navigation

    Previous PostU.S. Patent Allowance For Methods Of Identifying A Biologically-Active Composition From A BiofilmNext PostQuorum Innovations Demonstrates Human Microbiome Modulation

    Categories

    • In the News
    • Press Releases

    Recent Posts

    • DR. NICHOLAS MONSUL – CHAIRMAN/FOUNDER OF QUORUM INNOVATIONS KEY SPEAKER AT THE MICROBIOME SUMMIT IN VIENNA, AUSTRIA
    • Quorum Innovations Demonstrates Human Microbiome Modulation
    • Quorum Innovations is included in Silicon Valley Bank’s report on Microbiome Investment Trends.
    • U.S. Patent Allowance For Methods Of Identifying A Biologically-Active Composition From A Biofilm
    • QUORUM INNOVATIONS ANNOUNCES AVAILABILITY OF HUMAN MICROBIOME THERAPEUTICS TO TREAT COMMON SKIN CONDITIONS AND METABOLIC DISORDERS

    Archives

    • September 2017
    • August 2017
    • October 2016
    • September 2016
    • January 2015
    • June 2012

    Quorum Innovations

    2068 Hawthorne Street
    Sarasota, FL 34239
    Mon - Fri | 8:30-5:00
    +1 (941) 951-0126

    About Us

    Quorum Innovations is a specialty biopharmaceutical company focused on discovering, developing and delivering innovative biotherapeutics to physicians and their patients. Developing therapeutics based on a unique understanding of the role the human microbiome plays in health and disease, Quorum is poised to become a leader in the emerging field of microbiome therapeutics.

    Navigation

    • Home
    • About Us
    • A New Paradigm
    • Pipeline
    • News
    • Careers
    • Contact

    Newsletter

    • © 2024 Quorum Innovations, All Rights Reserved.